2,497
Views
33
CrossRef citations to date
0
Altmetric
Original Research

Immune checkpoint blockade reveals the stimulatory capacity of tumor-associated CD103+ dendritic cells in late-stage ovarian cancer

, , , , &
Article: e1185583 | Received 09 Mar 2016, Accepted 27 Apr 2016, Published online: 29 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Claire Vanpouille-Box, Claire Lhuillier, Lucillia Bezu, Fernando Aranda, Takahiro Yamazaki, Oliver Kepp, Jitka Fucikova, Radek Spisek, Sandra Demaria, Silvia C. Formenti, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Immune checkpoint blockers for cancer therapy. OncoImmunology 6:11.
Read now
Abhishek D. Garg, Monica Vara Perez, Marco Schaaf, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Dendritic cell-based anticancer immunotherapy. OncoImmunology 6:7.
Read now

Articles from other publishers (31)

Peng Liu, Liwei Zhao, Guido Kroemer & Oliver Kepp. (2023) Conventional type 1 dendritic cells (cDC1) in cancer immunity. Biology Direct 18:1.
Crossref
Aris J. Kare, Lisa Nichols, Ricardo Zermeno, Marina N. Raie, Spencer K. Tumbale & Katherine W. Ferrara. (2023) OMIP‐095 : 40‐Color spectral flow cytometry delineates all major leukocyte populations in murine lymphoid tissues . Cytometry Part A 103:11, pages 839-850.
Crossref
Zineb Kabala, Mouna Bourhafour, Tarik Chekrine, Zineb Bouchbika, Nadia Benchekroun, Hassan Jouhadi, Nezha Tawfiq, Abdallah Badou & Souha Sahraoui. (2023) Epithelial Ovarian Cancer: Microenvironment and Immunecheck Point Inhibitors. European Journal of Medical and Health Sciences 5:5, pages 17-26.
Crossref
Dallas B. Flies, Solomon Langermann, Christina Jensen, Morten A. Karsdal & Nicholas Willumsen. (2023) Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix. Frontiers in Immunology 14.
Crossref
Zhennan Yuan, Yingpu Li, Sifan Zhang, Xueying Wang, He Dou, Xi Yu, Zhiren Zhang, Shanshan Yang & Min Xiao. (2023) Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Molecular Cancer 22:1.
Crossref
Yusha Wang, Lei Zhang, Yun Bai, Li Wang & Xuelei Ma. (2022) Therapeutic implications of the tumor microenvironment in ovarian cancer patients receiving PD-1/PD-L1 therapy. Frontiers in Immunology 13.
Crossref
Jiang Deng, Qian Zhang, Liping Lv, Ping Ma, Yangyang Zhang, Ning Zhao & Yanyu Zhang. (2022) Identification of an autophagy-related gene signature for predicting prognosis and immune activity in pancreatic adenocarcinoma. Scientific Reports 12:1.
Crossref
Hajar Alemohammad, Basira Najafzadeh, Zahra Asadzadeh, Amir Baghbanzadeh, Farid Ghorbaninezhad, Arezoo Najafzadeh, Hossein Safarpour, Renato Bernardini, Oronzo Brunetti, Margherita Sonnessa, Rossella Fasano, Nicola Silvestris & Behzad Baradaran. (2022) The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer. Biomedicine & Pharmacotherapy 146, pages 112516.
Crossref
Jasmine J M Chuah, Paul J Hertzog & Nicole K Campbell. (2022) Immunoregulation by type I interferons in the peritoneal cavity. Journal of Leukocyte Biology 111:2, pages 337-353.
Crossref
Sanjay Rathod. 2022. Cellular Immunity in the Peritoneum. Cellular Immunity in the Peritoneum 15 41 .
Johanna C. Hoffmann & Michael P. Schön. (2021) Integrin αE(CD103)β7 in Epithelial Cancer. Cancers 13:24, pages 6211.
Crossref
Qian Zhang, Liping Lv, Ping Ma, Yangyang Zhang, Jiang Deng & Yanyu Zhang. (2021) Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma. Frontiers in Immunology 12.
Crossref
Mingyong Liu, Aaron Silva-Sanchez, Troy D Randall & Selene Meza-Perez. (2021) Specialized immune responses in the peritoneal cavity and omentum. Journal of Leukocyte Biology 109:4, pages 717-729.
Crossref
Kathryn M. Appleton, Ashley K. Elrod, Katy A. Lassahn, Stephen Shuford, Lillia M. Holmes & Teresa M. DesRochers. (2021) PD-1/PD-L1 checkpoint inhibitors in combination with olaparib display antitumor activity in ovarian cancer patient-derived three-dimensional spheroid cultures. Cancer Immunology, Immunotherapy 70:3, pages 843-856.
Crossref
Ángela Bella, Claudia Augusta Di Trani, Myriam Fernández-Sendin, Leire Arrizabalaga, Assunta Cirella, Álvaro Teijeira, José Medina-Echeverz, Ignacio Melero, Pedro Berraondo & Fernando Aranda. (2021) Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications. Cancers 13:5, pages 963.
Crossref
Xi Zhang, Tianhui He, Yuan Li, Ling Chen, Hongyu Liu, Yu Wu & Hongyan Guo. (2021) Dendritic Cell Vaccines in Ovarian Cancer. Frontiers in Immunology 11.
Crossref
Maureen L. Drakes & Patrick J. Stiff. 2021. Ovarian Cancer: Molecular & Diagnostic Imaging and Treatment Strategies. Ovarian Cancer: Molecular & Diagnostic Imaging and Treatment Strategies 33 54 .
Maureen L. Drakes, Cheryl M. Czerlanis & Patrick J. Stiff. (2020) Immune Checkpoint Blockade in Gynecologic Cancers: State of Affairs. Cancers 12:11, pages 3301.
Crossref
Henrik J. Jürgensen, Sander van Putten, Kirstine S. Nørregaard, Thomas H. Bugge, Lars H. Engelholm, Niels Behrendt & Daniel H. Madsen. (2020) Cellular uptake of collagens and implications for immune cell regulation in disease. Cellular and Molecular Life Sciences 77:16, pages 3161-3176.
Crossref
Ben Phillippi, Manindra Singh, Tiffany Loftus, Hannah Smith, Maria Muccioli, Julia Wright, Michelle Pate & Fabian Benencia. (2020) Effect of laminin environments and tumor factors on the biology of myeloid dendritic cells. Immunobiology 225:1, pages 151854.
Crossref
Heather L. MacGregor, Azin Sayad, Andrew Elia, Ben X. Wang, Sarah Rachel Katz, Patricia A. Shaw, Blaise A. Clarke, Sarah Q. Crome, Celine Robert-Tissot, Marcus Q. Bernardini, Linh T. Nguyen & Pamela S. Ohashi. (2019) High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Younghoon Kim, Yunjoo Shin & Gyeong Hoon Kang. (2019) Prognostic significance of CD103+ immune cells in solid tumor: a systemic review and meta-analysis. Scientific Reports 9:1.
Crossref
Sara Musetti & Leaf Huang. (2018) Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy. ACS Nano 12:12, pages 11740-11755.
Crossref
Laurie Hudson, Jennifer Gillette, Huining Kang, Melanie Rivera & Angela Wandinger-Ness. (2018) Ovarian Tumor Microenvironment Signaling: Convergence on the Rac1 GTPase. Cancers 10:10, pages 358.
Crossref
Mate Kiss, Sofie Van Gassen, Kiavash Movahedi, Yvan Saeys & Damya Laoui. (2018) Myeloid cell heterogeneity in cancer: not a single cell alike. Cellular Immunology 330, pages 188-201.
Crossref
Xiaolin Miao, Yiqi Chen, Ke Hao, Meiqin Zheng, Bingyu Chen, Kaiqiang Li, Ying Wang, Wei Zhang, Yu Zhang, Xiaozhou Mou, Shanshan Jiang & Zhen Wang. (2018) CD103 + Cell Growth Factor Flt3L Enhances the Efficacy of Immune Checkpoint Blockades in Murine Glioblastoma Model . Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 26:2, pages 173-182.
Crossref
Peiliang Wang, Bing Huang, Yi Gao, Jianjian Yang, Zhihui Liang, Ni Zhang, Xiangning Fu & Lequn Li. (2018) CD103 + CD8 + T lymphocytes in non-small cell lung cancer are phenotypically and functionally primed to respond to PD-1 blockade. Cellular Immunology 325, pages 48-55.
Crossref
Felix S. Lichtenegger, Maurine Rothe, Frauke M. Schnorfeil, Katrin Deiser, Christina Krupka, Christian Augsberger, Miriam Schlüter, Julia Neitz & Marion Subklewe. (2018) Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells. Frontiers in Immunology 9.
Crossref
Chen Varol & Irit Sagi. (2017) Phagocyte—extracellular matrix crosstalk empowers tumor development and dissemination. The FEBS Journal 285:4, pages 734-751.
Crossref
Andreas Schlitzer, Wei Zhang, Mei Song & Xiaojing Ma. (2018) Recent advances in understanding dendritic cell development, classification, and phenotype. F1000Research 7, pages 1558.
Crossref
Jiri Keirsse, Helena Van Damme, Jo A Van Ginderachter & Damya Laoui. (2017) Exploiting tumor-associated dendritic cell heterogeneity for novel cancer therapies. Journal of Leukocyte Biology 102:2, pages 317-324.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.